Protein kinase C inhibitors: a patent review (2010 – present)

Author： Sobhia Masilamani Elizabeth   Grewal Baljinder K   Paul Matam Losery Stanly   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.11, 2013-11, pp. : 1451-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinase C inhibitors: a patent review (2008 – 2009)

By Sobhia M Elizabeth   Grewal Baljinder K   ML Stanly Paul   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1297-1315

Informa Healthcare

Access to resources Recommend Favorite

Checkpoint kinase inhibitors: a patent review (2009 –– 2010)

By Lainchbury Michael   Collins Ian  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1191-1210

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

By Magrioti Victoria   Kokotos George  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 – 2013

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 573-595

Informa Healthcare

Access to resources Recommend Favorite